| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 113,942,156 | 67,679,097 | ||
| Accounts receivable | 17,425,680 | 649,476 | ||
| Inventories | 1,371,738 | 1,045,612 | ||
| Receivable from noncontrolling interests | 0 | 0 | ||
| Note receivable | 31,189,144 | 30,363,798 | ||
| Lease receivable - current | 16,733 | 16,273 | ||
| Prepaid expenses and other current assets | 10,099,525 | 1,834,245 | ||
| Total current assets | 174,044,976 | 101,588,501 | ||
| Property and equipment, at cost | 33,004,846 | - | ||
| Accumulated deprecation | 2,074,611 | - | ||
| Property and equipment, net | 30,930,235 | 27,600,294 | ||
| Operating lease right-of-use assets, net | 971,658 | 1,016,560 | ||
| Deferred tax assets | 68,008 | 33,509 | ||
| Intangible assets | 1,190,562 | - | ||
| Goodwill | 6,849,119 | 3,362,650 | ||
| Lease receivable - noncurrent | 410,223 | 376,314 | ||
| Equity method investments | 1,322,900 | - | ||
| Other investments | 5,000,000 | - | ||
| Other noncurrent assets | 5,102,480 | 1,936,664 | ||
| Total assets | 225,890,161 | 135,914,492 | ||
| Accounts payable | 3,424,698 | 2,600,670 | ||
| Accrued expenses | 3,655,761 | 1,792,652 | ||
| Notes payable - current | - | 342,080 | ||
| Debt - current | 12,401,279 | - | ||
| Finance lease liabilities - current | 166,459 | 145,976 | ||
| Operating lease liabilities - current | 468,569 | 500,873 | ||
| Deferred revenue | 882,000 | 882,000 | ||
| Due to related parties | 3,438,275 | - | ||
| Other current liabilities | 3,666,092 | 489,584 | ||
| Share liability | 220,635 | 149,766 | ||
| Total current liabilities | 28,323,768 | 6,903,601 | ||
| Deferred tax liabilities | 307,807 | - | ||
| Convertible notes payable, at fair value | 97,975,479 | 98,148,315 | ||
| Debt - noncurrent | 1,534,686 | 1,393,519 | ||
| Finance lease liabilities - noncurrent | 492,103 | 518,578 | ||
| Operating lease liabilities - noncurrent | 617,988 | 639,419 | ||
| Other noncurrent liabilities | 34,353 | - | ||
| Total liabilities | 129,286,184 | 107,603,432 | ||
| Common stock, 0.01 par value 500,000,000 shares authorized, 93,376,629 and 72,068,059 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 933,766 | 839,054 | ||
| Additional paid-in capital | 224,740,838 | 164,045,692 | ||
| Accumulated deficit | -152,555,942 | -139,681,935 | ||
| Accumulated other comprehensive income (loss) | 949,855 | 29,148 | ||
| Total stockholders' equity attributed to asp isotopes inc. stockholders | 74,068,517 | 25,231,959 | ||
| Noncontrolling interests in consolidated subsidiaries | 22,535,460 | 3,079,101 | ||
| Total stockholders' equity | 96,603,977 | 28,311,060 | ||
| Total liabilities and stockholders' equity | 225,890,161 | 135,914,492 | ||
ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc. (ASPI)